KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Short term Debt: 2009-2022

Historic Short term Debt for Charles River Laboratories International (CRL) over the last 14 years, with Sep 2022 value amounting to $2.1 million.

  • Charles River Laboratories International's Short term Debt fell 8.62% to $2.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $2.1 million, marking a year-over-year decrease of 8.62%. This contributed to the annual value of $2.8 million for FY2021, which is 94.43% down from last year.
  • According to the latest figures from Q3 2022, Charles River Laboratories International's Short term Debt is $2.1 million, which was down 12.06% from $2.4 million recorded in Q2 2022.
  • Charles River Laboratories International's Short term Debt's 5-year high stood at $53.7 million during Q2 2020, with a 5-year trough of $2.1 million in Q3 2022.
  • For the 3-year period, Charles River Laboratories International's Short term Debt averaged around $19.8 million, with its median value being $2.9 million (2021).
  • Per our database at Business Quant, Charles River Laboratories International's Short term Debt spiked by 877.21% in 2019 and then slumped by 95.26% in 2021.
  • Quarterly analysis of 5 years shows Charles River Laboratories International's Short term Debt stood at $31.4 million in 2018, then increased by 22.69% to $38.5 million in 2019, then surged by 30.27% to $50.2 million in 2020, then tumbled by 94.43% to $2.8 million in 2021, then declined by 8.62% to $2.1 million in 2022.
  • Its last three reported values are $2.1 million in Q3 2022, $2.4 million for Q2 2022, and $2.6 million during Q1 2022.